Altamira Therapeutics Ltd. Key Management Personnel Compensation
Altamira Therapeutics Ltd. (CYTOF) reported Key Management Personnel Compensation of $1.22 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensation · last filed 2025-04-30
CHF
| Period end | Key Management Personnel Compensation 12 month |
|---|---|
| 2023-12-31 | 1.10M CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 1.45M CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 2.12M CHF 20-F/A · filed 2024-04-22 |
| 2020-12-31 | 859.48K CHF 20-F · filed 2023-05-16 |
| 2019-12-31 | 1.09M CHF 20-F · filed 2022-04-12 |
| 2018-12-31 | 1.52M CHF 20-F · filed 2021-03-31 |
| 2017-12-31 | 2.22M CHF 20-F · filed 2020-04-16 |
| 2016-12-31 | 2.29M CHF 20-F · filed 2019-03-14 |
| 2015-12-31 | 1.95M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Key Management Personnel Compensation 12 month |
|---|---|
| 2024-12-31 | $1.22M 20-F · filed 2025-04-30 |
| 2023-12-31 | $1.23M 20-F · filed 2025-04-30 |
| 2022-12-31 | $1.51M 20-F · filed 2025-04-30 |